Detalhe da pesquisa
1.
Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples.
Br J Cancer
; 122(7): 953-956, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32094484
2.
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
Br J Cancer
; 122(8): 1166-1174, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147669
3.
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel.
Int J Cancer
; 136(6): E760-72, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25242736
4.
Risk of thromboembolic events after perioperative chemotherapy versus surgery alone for esophageal adenocarcinoma.
Ann Surg Oncol
; 19(2): 684-92, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21837523
5.
Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
Front Oncol
; 12: 969855, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36147916
6.
High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Clin Epigenetics
; 13(1): 196, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670587
7.
Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer.
J Thromb Haemost
; 19(12): 2974-2983, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34409743
8.
Fibronectin is a hypoxia-independent target of the tumor suppressor VHL.
FEBS Lett
; 556(1-3): 137-42, 2004 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-14706840
9.
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial).
Trials
; 13: 230, 2012 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23199187